RELA NEELY: Open Payments
NPI 1700943933 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,949 in 68 payments from 13 companies in 2025. Trend: 2023 $783 · 2024 $1,521 · 2025 $1,949
Food & beverage: $1,949
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $505 |
| AstraZeneca Pharmaceuticals LP | 8 | $477 |
| Novo Nordisk Inc | 12 | $329 |
| Phathom Pharmaceuticals, Inc. | 1 | $124 |
| Amgen Inc. | 1 | $122 |
| Lilly USA, LLC | 5 | $104 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $58 |
| PFIZER INC. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
Products named: QULIPTA, BREZTRI, VRAYLAR, AIRSUPRA, VOQUEZNA, REPATHA, Wegovy, Rybelsus.
Industry payments across TX — which companies pay providers there.
